Semnur Pharmaceuticals, Inc. (OTCPK: SMNR)
Health Care · Pharmaceuticals · US
$0.45
-24.87% today · -95.0% 1Y
Semnur Pharmaceuticals, Inc. (OTCPK: SMNR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $103.59M.
Over the last twelve months the share price has lost 95.0%, trading between 0.13 and 23.00.
Tweenvest scores Semnur Pharmaceuticals, Inc. across four factors: quality 6/100, value 52/100. Its strongest factor is value.
SMNR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $103.59M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.76
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- $23.00
- 52-week low
- $0.13
- Avg volume (3M)
- —
- Shares outstanding
- 230.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vita Life Sciences LimitedASX: VLS | $104.53M | AU$2.78 | -0.71% |
| SYN-TECH Chem. & Pharm. Co., Ltd.TPEX: 1777 | $104.15M | NT$74.40 | +0.13% |
| Medexus Pharmaceuticals Inc.TSX: MDP | $104.05M | CA$4.72 | -7.81% |
| Polaryx Therapeutics, Inc.NasdaqCM: PLYX | $103.68M | $2.00 | -3.85% |
| Aardvark Therapeutics, Inc.NasdaqGS: AARD | $103.08M | $4.71 | -5.04% |
| October Pharma S.A.ECASE: OCPH | $102.66M | EGP223.92 | -0.76% |
| Stablecoin Development CorporationNYSEAM: SDEV | $100.72M | $1.99 | -28.42% |
| NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo ReszvenytarsasagBUSE: NATURLAND | $100.56M | Ft2,380.00 | -15.00% |
Figures last refreshed Oct 4, 2026.